My name is Famke. I’m originally from Germany and have been living in the U.S. since 2008. I am now in the Bay Area and […]
My ILC Story: Meet Famke and Hear Her Lobular Breast Cancer Story Read More »
A major milestone for the lobular breast cancer research community was attained with the launch of the Lobular American Research Consortium (LARC), the first national,
Lobular Breast Cancer Alliance (LBCA) is proud to celebrate two members of our team who were recently named to OncoDaily’s 100 Most Influential Cancer Survivors
LBCA Staff Recognized in Oncodaily’s 100 Influential Cancer Survivors on Social Media Read More »
Researchers at the University of Colorado Anschutz Cancer Center have launched the Lobular Breast Cancer Initiative (LBCI), a new interdisciplinary program dedicated to advancing research
New ILC Focused Initiative at University of Colorado Anschutz Cancer Center Read More »
LBCA is excited to welcome Mary Pat Landry to the LBCA Board of Directors. A Louisiana native, Mary earned a Bachelor of Arts in Psychology
LBCA Welcomes New Board Member Mary Pat Landry Read More »
LBCA is thrilled to welcome Lauren Sebesta as Manager of Marketing and Communications. Lauren holds a Bachelor of Arts in Biology from Binghamton University and
LBCA Welcomes New Staff Member Lauren Sebesta, Marketing & Communications Manager Read More »
LBCA advocates continue to raise awareness and educate about lobular breast cancer through local events! New York We applaud Maureen Terranova who spread the word
Advocacy in Action in New York and Montana Read More »
LBCA Scientific Advisory Board member, Dr. George Sflomos, recently published a research article LOX Inhibition Disrupts a Collagen–Integrin–MYC Axis to Suppress Progression of Invasive Lobular
LBCA encourages ILC patients to participate in breast cancer clinical trials to help ensure that there is sufficient participation by those with ILC to enable
"*" indicates required fields
